5 hemophilia facts you might not know

Hemophilia, a rare bleeding disorder, is a typically hereditary disease in which the blood does not clot properly. This can lead to spontaneous bleeding as well as bleeding following injuries or surgery. We explore a few key hemophilia facts that you might not know. 

Continue reading

The Antidote recruitment solution [infographic]

It’s no secret that clinical trial recruitment can be challenging. From initial engagement with the right patients, to tracking recruitment at the site level, to juggling vendors, it’s no wonder patient recruitment takes an estimated 30% of the trial process. 

Continue reading

Ulcerative colitis vs. Crohn's disease: What's the difference?

Inflammatory bowel disease (IBD) is characterized by a group of intestinal disorders that cause inflammation of the digestive tract. The two most common kinds of IBD are ulcerative colitis (UC) and Crohn’s disease. Often, patients with Crohn’s and UC present similar symptoms, such as abdominal pain, diarrhea, and rectal bleeding, but the two conditions are actually quite different. We look at the ...

Continue reading

Why your clinical trial advertising might be missing the mark

Are you spending time and money on clinical trial advertising that’s not delivering? It can be frustrating to put resources into spreading the word about your study, only to find that the patients who make it to your sites are not right for your trial. According to a survey Antidote conducted of 4,000+ patients, 52% of patients found out about clinical trial opportunities through an ...

Continue reading

How a patient moves through a clinical trial [infographic]

Enrolling in a clinical trial is a big decision. It’s important to speak with friends, family members, health care providers, and other people living with your condition to make your decision about participation. But even then, the process can be a bit confusing. 

Continue reading

What does study start up look like at clinical trial recruitment companies?

Getting a clinical trial started is often a collaborative effort between a number of different teams, from sponsors to sites to patient recruitment organizations. When it comes to clinical trial recruitment companies, what exactly does study start up look like? We spoke with Antidote’s Senior Manager of Strategic Client Services, Amrita Bhatt, about what it takes to kick off a new clinical trial ...

Continue reading

How to get the most out of your clinical trial search

You’ve decided that you want to participate in a clinical trial for your condition. Great! Digital health companies like Antidote have tools to help you find your clinical trial matches quickly. But just because the matching tools exist, you still want to make sure you’re getting the most out of your clinical trial search. Here’s what to look for to maximize your clinical trial search.

Continue reading

Webinar recap: Painting a portrait of the melanoma clinical trial participant

On June 24, Melanoma Research Alliance’s (MRA) Chief Science Officer Marc Hurlbert and Director of Communications Cody Barnett joined Antidote's Head of Partnerships Lindsey Wahlstrom-Edwards in a webinar to discuss what matters most to melanoma patients when it comes to participating in clinical trials. The conversation, informed by a 2018 study of 444 melanoma patients and survivors, provided ...

Continue reading

Top 6 COVID-19 and clinical trials webinars and podcasts

With the rapid spread of COVID-19, sponsors, sites, CROs, and patients have had to adapt to our new virtual reality. There are many webinars and podcasts available, and we know it can be hard to choose what to tune in to. What follows is a list of webinars and podcasts that thoughtfully break down the changing nature of clinical trials in light of the COVID-19 pandemic and look at the state of ...

Continue reading

Bladder cancer clinical trial match and a Q&A with the Crush It For Curtis Foundation team

More than 80,000 people in the US will be diagnosed with bladder cancer this year. Treatment options have come a long way, and now include surgery, radiation, and chemotherapy — but many come with less than desirable side effects, and bladder cancer may recur. Research in this area is critical. 

Continue reading

Get our latest posts in your inbox.